Form 4: INSMED COO Roger Adsett Sells Shares to Cover Tax Obligations

INSMED Inc.'s Chief Operating Officer, Roger Adsett, sold 1,860 shares of common stock for $71.5 per share to cover tax withholding obligations and broker fees related to vested Restricted Stock Units.

Summary

• Roger Adsett, Chief Operating Officer of INSMED Inc., reported a transaction on June 3, 2025.
• He disposed of 1,860 shares of INSMED Common Stock at a price of $71.5 per share.
• The sale was conducted to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.
• Following this transaction, Mr. Adsett beneficially owns 141,323 shares of INSMED Common Stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's a sale of shares, the stated reason (tax withholding and broker fees on RSU vesting) indicates it's a non-discretionary transaction, which is generally not interpreted as a lack of confidence in the company by the insider.

Positives

• The sale was explicitly stated to be for tax withholding obligations and broker fees, indicating it was not a discretionary sale based on a negative outlook on the company.

Negatives

• The transaction resulted in a reduction of insider ownership by 1,860 shares.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction, common across all publicly traded companies, and does not provide specific insights into broader industry trends or competitive landscape within the biotechnology or pharmaceutical sector.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but the reason for the sale (tax obligations) suggests no negative implications for company performance or outlook.
• Employees: No direct impact mentioned.

Key Dates

Keywords

INSMED Inc., INSM, Form 4, Insider Transaction, Roger Adsett, Chief Operating Officer, Stock Sale, Restricted Stock Units, Tax Withholding